Showing results (31-40 of 107) with videos related to
Sort By:
Pageof 11
The Oncologist|July 3, 2007
New drugs for myelomaPaul G Richardson, Constantine Mitsiades, Robert Schlossman, et al.Oncogene|December 4, 2003
Biologic sequelae of c-Jun NH(2)-terminal kinase (JNK) activation in multiple myeloma cell linesTeru Hideshima, Toshiaki Hayashi, Dharminder Chauhan, et al.International Journal of Oncology|June 26, 2008
MUC1 oncoprotein promotes growth and survival of human multiple myeloma cellsTakeshi Kawano, Rehan Ahmad, Hiroko Nogi, et al.The Journal of Physical Chemistry Letters|July 14, 2018
Unraveling Photodimerization of Cyclohexasilane from Molecular Dynamics StudiesYulun Han, Kenneth Anderson, Erik K Hobbie, et al.Nature Reviews. Clinical Oncology|February 22, 2012
Latest advances and current challenges in the treatment of multiple myelomaAnuj Mahindra, Jacob Laubach, Noopur Raje, et al.Clinical Lymphoma & Myeloma|October 20, 2005
Emerging trends in the clinical use of bortezomib in multiple myelomaPaul G Richardson, Robert Schlossman, Constantine Mitsiades, et al.Journal of the National Comprehensive Cancer Network : JNCCN|February 10, 2010
Complications of multiple myeloma therapy, part 1: risk reduction and management of peripheral neuropathy and astheniaPaul G Richardson, Jacob P Laubach, Robert L Schlossman, et al.Pilot and Feasibility Studies|July 8, 2022
Enhancing national audit through addressing the quality improvement capabilities of feedback recipients: a multi-phase intervention development studyMichael Sykes, Elaine O'Halloran, Lucy Mahon, et al.Obstetric Medicine|September 2, 2016
Multiple pneumothoraces during second and third trimesters as first presentation of lymphangioleiomyomatosisRuth McCartney, Nicola Facey, George Chalmers, et al.Polish Archives of Internal Medicine|April 15, 2025
New therapies in multiple myeloma: benefits and limitationsArtur Jurczyszyn, Michał Bator, Dav H Vesole, et al.Pageof 11